S Shiva , MD R Sarisorkhabi , MD
Received: 24 Oct, 2007 Accepted: 12 March, 2008
Abstract
Background & Aims: Combination of chelating therapy regimens with regular blood transfusion has significantly improved the life expectancy of thalassemic patients. Despite progresses in treatment of these patients, growth failure, and short stature are found in significant number of them. Factors such...